Literature DB >> 12456332

Clinical management of chronic Chagas cardiomyopathy.

Manoel O C Rocha1, Antonio Luiz P Ribeiro, Mauro M Teixeira.   

Abstract

Chagas disease is caused by a protozoan parasite, Trypanosoma cruzi, and infects over 15 million people worldwide. New cases of the disease are now uncommon, mainly due to national control programs in Latin America. However, there is a large reservoir of chronically infected patients, many of whom will develop chagasic cardiopathy. Here, the clinical diagnosis and management of Chagas cardiopathy are discussed. Particular emphasis is placed on the clinical staging of patients and the use of various diagnostic tests that may be useful in individualizing treatment of the two most relevant clinical syndromes, ie. heart failure and arrhythmias. Finally, the relevance of specific treatment is discussed, stressing the important role of parasite persistence for disease pathogenesis.

Entities:  

Mesh:

Year:  2003        PMID: 12456332     DOI: 10.2741/926

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  36 in total

1.  Role of CCL3/MIP-1alpha and CCL5/RANTES during acute Trypanosoma cruzi infection in rats.

Authors:  Ester Roffê; Fabiano Oliveira; Adriano L S Souza; Vanessa Pinho; Danielle G Souza; Patrícia R S Souza; Remo C Russo; Helton C Santiago; Alvaro J Romanha; Herbert B Tanowitz; Jesus G Valenzuela; Mauro M Teixeira
Journal:  Microbes Infect       Date:  2010-05-07       Impact factor: 2.700

2.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

Review 3.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

4.  Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease.

Authors:  C A S Menezes; A K Sullivan; M T Falta; D G Mack; B M Freed; M O C Rocha; K J Gollob; A P Fontenot; W O Dutra
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

5.  Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.

Authors:  S M Keating; X Deng; F Fernandes; E Cunha-Neto; A L Ribeiro; B Adesina; A I Beyer; P Contestable; B Custer; M P Busch; E C Sabino
Journal:  Int J Cardiol       Date:  2015-07-12       Impact factor: 4.164

Review 6.  Advances and challenges towards a vaccine against Chagas disease.

Authors:  Israel Quijano-Hernandez; Eric Dumonteil
Journal:  Hum Vaccin       Date:  2011-11-01

7.  Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease.

Authors:  Rafaelle Christine Gomes Fares; Juliana de Assis Silva Gomes; Luciana Ribeiro Garzoni; Mariana Caldas Waghabi; Roberto Magalhães Saraiva; Nayara Ingrid Medeiros; Roberta Oliveira-Prado; Luiz Henrique Conde Sangenis; Mayara da Costa Chambela; Fernanda Fortes de Araújo; Andréa Teixeira-Carvalho; Marcos Paulo Damásio; Vanessa Azevedo Valente; Karine Silvestre Ferreira; Giovane Rodrigo Sousa; Manoel Otávio da Costa Rocha; Rodrigo Correa-Oliveira
Journal:  Infect Immun       Date:  2013-07-15       Impact factor: 3.441

Review 8.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

9.  Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.

Authors:  Paulo E A Souza; Manoel O C Rocha; Cristiane A S Menezes; Janete S Coelho; Andréa C L Chaves; Kenneth J Gollob; Walderez O Dutra
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

10.  Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients.

Authors:  Ana Luiza Lunardi Rocha; Federico Lombardi; Manoel Otávio da Costa Rocha; Márcio Vinícius Lins Barros; Vladimir da Costa Val Barros; Adelina Martha Reis; Antonio Luiz Pinho Ribeiro
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.